Brain Tumor Drugs Market Size to Surpass USD 3.72 Billion in 2030, exhibiting a CAGR of 10.2%

Advertisement

As per the report by Fortune Business Insights, The global Brain tumor drugs market size was valued at USD 1.80 billion in 2022. The market is projected to expand from USD 1.89 billion in 2023 to USD 3.72 billion by 2030, exhibiting a CAGR of 10.2% over the estimated period.

Brain Tumor Drug Market

Forecast 2023-2030
Forecast 2023-2030

Pune, India, Sept. 04, 2023 (GLOBE NEWSWIRE) — The global Brain tumor drugs market size was valued at USD 1.80 billion in 2022 and is projected to USD 3.72 billion by 2030, exhibiting a CAGR of 10.2% over estimated period. The rise is driven by the increasing aging population and the growing prevalence of smoking.

Fortune Business Insights™ provides this information in its research report, titled “Brain Tumor Drugs Market, 2023-2030”.

Key Industry Development:

June 2022 – Novartis secured the approval of the U.S. Food and Drug Administration for dabrafenib (Tafinlar) and trametinib (Mekinist) for treating adult and pediatric patients with metastatic or unresectable solid tumors with BRAF V600E mutation.

Request a Sample PDF : https://www.fortunebusinessinsights.com/enquiry/sample/brain-tumor-drugs-market-105025


Key Takeaways :

Advertisement

  • Deferred Diagnosis of New Cases during Pandemic Affected Market Growth
  • Advancements in Diagnosis to Support Market Growth
  • Rising Prevalence of Brain Cancer Cases to Propel Market Growth
  • Strong Presence of Pipeline Candidates to Support Market Growth  
  • Comparatively Lower Diagnosis and Treatment Rates Coupled with Limited Reimbursement May Decline Market Growth
  • F. Hoffmann-La Roche AG is Leading the Market Owing to Strong Portfolio of Drugs

List of Key Players Mentioned in the Report:

  • F. Hoffmann-La Roche Ltd (U.S.)
  • Novartis AG (Switzerland)
  • Merck & Co. Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Amgen Inc. (U.S.)
  • NextSource Pharmaceuticals, LLC (U.S.)
  • Emcure Pharmaceuticals (India)

COVID-19 Impact:

Market Expansion Impacted by Delayed Diagnosis of New Cases

The market was negatively affected by the COVID-19 pandemic driven by a decline in the diagnosis of new cases. Besides, the period registered a reduced rate of treatment. There was a substantial decline in the revenue in generated by several companies. The industry growth was revived by the growing adoption of favorable initiatives by the governments of various countries.


To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/brain-tumor-drugs-market-105025


Report Scope & Segmentation:

Report Coverage Details
Forecast Period 2023 to 2030
Forecast Period 2023 to 2030 CAGR 10.2%
2030 Value Projection USD 3.72 Billion
Base Year 2022
Brain Tumor Drugs Market Size in 2022 USD 1.80 Billion
Historical Data for 2019 to 2021
No. of Pages 181
Segments covered By Therapy, By Indication, By Distribution


Segments:

Chemotherapy Segment to Register Notable Traction Driven by Rise in Number of Patients

On the basis of therapy, the market for brain tumor drugs is subdivided into chemotherapy, targeted therapy, immunotherapy, and others. The chemotherapy segment held the largest market share in 2022 and is slated to record substantial growth over the study period. The rise is impelled by the growing deployment of chemotherapy for treating brain tumors.

Glioma Segment to Lead Owing to Rising Prevalence of Malignant Brain Tumor

Based on indication, the market for brain tumor drugs is fragmented into meningioma, pituitary, glioma, and others. The glioma segment accounted for a dominating share in the market in 2022 and is anticipated to grow at a considerable CAGR over the projected period. The expansion is propelled by the increasing launch of drugs for the treatment of glioblastoma.

Hospital Pharmacy Segment to Hold Key Share Driven by Growing Number of Hospital Admissions

On the basis of distribution channel, the market for brain tumor drugs is categorized into retail & online pharmacy and hospital pharmacy. The hospital pharmacy segment held a major share in the market in 2022. The dominance can be credited to the surging number of hospital admissions owing to drug prescription (post diagnosis) and administration in these settings.  

Based on geography, the market for brain tumor drugs has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Quick Buy – Brain Tumor Drugs Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/105025


Report Coverage:

The report gives a substantial coverage of the major trends driving the global business scenario throughout the forecast period. It further delves into the key factors impelling the industry expansion over the forthcoming years. The report also provides an account of the key strategies adopted by leading market players for establishing strong industry footings.  

Drivers and Restraints:

Surge in Market Value on Account of Increasing Prevalence of Brain Cancer Cases

One of the key factors propelling the brain tumor drugs market growth is the increasing prevalence of cancer on account of growing urbanization and lifestyle changes. The growth of cancer cases is mainly driven by the escalating prevalence of smoking.

However, the market expansion may be hampered by the lack of reimbursement policies in developing countries for treating brain tumor.   

Regional Insights:

North America Held Dominant Share Driven by Presence of Appropriate Reimbursement Policies

The North America brain tumor drugs market share led the market in 2022 and is slated to record notable growth over the study period. The rise is propelled by the surging launch of new drugs and the presence of apt reimbursement policies in the country.

The Europe market value is anticipated to grow at a lucrative pace over the projected period. The expansion is driven by the increasing focus on research activities for drug development.

Competitive Landscape:

Major Industry Players Forge Collaborations to Expand Product Reach

Leading market participants are undertaking various steps for expanding the reach of their products. These include merger agreements, partnerships, collaborations, and acquisitions, among others. Besides, companies are also keen to invest in research activities for the development and launch of new drugs.

Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/brain-tumor-drugs-market-105025


Table Of Contents :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Incidence of Brain Cancer, Key Region, 2020/2021
    • Key Industry Developments – Mergers, Partnerships, Acquisitions
    • Overview of the Regulatory Scenario by Key Region/Countries
    • New Product Launches by Key Players
    • Impact of COVID-19 on Brain Tumor Drugs Market
  • Global Brain Tumor Drugs Market Analysis, Insights and Forecast, 2019-2030
    • Market Analysis, Insights and Forecast – By Therapy
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
    • Market Analysis, Insights and Forecast – By Indication
      • Pituitary Tumors
      • Meningioma
      • Glioblastoma
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •  Hospital Pharmacy
      •  Retail & Online Pharmacy
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Brain Tumor Drugs Market Analysis, Insights and Forecast, 2019-2030
    • Market Analysis, Insights and Forecast – By Therapy
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
    • Market Analysis, Insights and Forecast – By Indication
      • Pituitary Tumors
      • Meningioma
      • Glioblastoma
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •  Hospital Pharmacy
      •  Retail & Online Pharmacy
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
        • By Indication
      • Canada
        • By Indication

Toc Continue…

FAQs :

How big is the Brain Tumor Drugs Market?

  • The global brain tumor drugs market size was valued at USD 1.80 billion in 2022. The market is projected to grow from USD 1.89 billion in 2023 to USD 3.72 billion by 2030, exhibiting a CAGR of 10.2% during the forecast period.

Which are the key factors driving the Brain Tumor Drugs Market?

  • Surge in brain cancer prevalence, presence of potential pipeline candidates, and increasing demand for precision and personalized medicine are the key factors set to spur the market growth.

Related Reports:

Flow Diverters Market Size, Share, Revenue Forecast and Opportunities

Aspiration Control Systems Market Overview, Industry Share and Forecast

Cellular Reprogramming Tools Market Size, Share, Opportunities & Analysis

Analytical Standards Market Analysis, Global Size and Industry Share Forecast

Hyperglycemia Treatment Market Size, Share, Opportunities and Forecast


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

Attachment

  • Brain Tumor Drug Market

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.